President Donald Trump triggered Monday’s stock market sell-off with his shifting tariff policies, which are bad news if they’re tactical and even worse if they’re a long-term strategies, market observers said.Read more... [...]
London-headquartered biotech startup Verdiva has emerged from stealth with a whopping $410mn for a new range of drugs aimed at tackling the obesity epidemic. It’s one of Europe’s largest-ever biotech VC deals, signalling investor appetite for the booming weight loss market. Verdiva looks to challenge the dominance of Novo Nordisk and Eli Lilly, the makers of the two most popular weight loss [...]